Spyre Therapeutics (SYRE) Q4 2021 Earnings

8MarExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
-7.75
-5.22
-2.69
-0.16

Details

Expected EPS
-0.2875
Actual EPS
-7.75
Surprise EPS
-7.46
Surprise Percent
+2,595.65%

Description

Spyre Therapeutics (SYRE) has reported earnings of -7.75 per share for Q4 2021.

0 Comments

Share your thoughts